Viromed Medical confirms full-year guidance after H1 revenue rises to €2.5 million
The company said it advanced product development and market launch efforts in the first half of 2026. H1 revenue rose to €2.5 million from €2.4 million a year earlier, while net loss widened to €1.1 million.